^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CycloSam (samarium-153 DOTMP)

    i
    Other names: 153-Sm-DOTMP, Sm-153-DOTMP, 153Sm-DOTMP
    Associations

    News

    Trials
    Company:
    Telix
    Drug class:
    Ionizing radiation emitter
    Related drugs:
    Associations

    News

    Trials
    1year
    Phase I evaluation of CycloSam (Sm-153-DOTMP) bone seeking radiopharmaceutical in dogs with spontaneous appendicular osteosarcoma. (PubMed, Vet Radiol Ultrasound)
    DOTMP (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene-phosphonate) is a macrocyclic chelating agent with superior binding properties to Sm when compared with EDTMP (Quadramet™, used for palliative treatment of bone cancer)...Carboplatin chemotherapy (300 mg/m2 IV every 3 weeks ×4) started 4 weeks after Sm-DOTMP injection...All dogs completed study monitoring. The recommended dose for CycloSam in dogs is 1.75 mCi/kg, which resulted in some pain control with minimal toxicity and was safely combined with chemotherapy.
    P1 data • Clinical Trial,Phase I • Journal
    |
    carboplatin • CycloSam (samarium-153 DOTMP) • Quadramet (samarium 153 lexidronam)
    1year
    A Dose Finding Study to Treat Bone Tumor(s) (clinicaltrials.gov)
    P1, N=17, Recruiting, QSAM Therapeutics, Inc.
    New P1 trial • Metastases
    |
    CD34 (CD34 molecule)
    |
    CycloSam (samarium-153 DOTMP)